Differential switching to IgG and IgA in active smoking COPD patients and healthy controls

European Respiratory Journal

Volumn 40, Issue 2, 2012, Pages 313-321

  Brandsma, Corry Anke ^a   Kerstjens, Huib A M ^a   Van Geffen, Wouter H ^a   Geerlings, Marie ^a   Postma, Dirkje S ^a   Hylkema, Machteld N ^a   Timen, Wim ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cigarette smoke; Decorin; Immune response; Lung tissue; Memory B cells

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M;

ADAPTIVE IMMUNITY; ADULT; AGED; ANTIBODY PRODUCING CELL; ARTICLE; B LYMPHOCYTE; CELL ISOLATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LUNG PARENCHYMA; LYMPHOCYTE ACTIVATION; MALE; MEMORY CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; B-LYMPHOCYTES; CASE-CONTROL STUDIES; DECORIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNE SYSTEM; IMMUNOGLOBULIN A; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN G; LEUKOCYTES; LEUKOCYTES, MONONUCLEAR; LUNG; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 84864443233     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00011211     Document Type: Article

References (46)

1. Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 2008; 8: 183-192. (Pubitemid 351323287)
2. Hogg JC, Timens W. The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol 2009; 4: 435-459.
3. Richmond I, Pritchard GE, Ashcroft T, et al. Bronchus associated lymphoid tissue (BALT) in human lung: its distribution in smokers and non-smokers. Thorax 1993; 48: 1130-1134. (Pubitemid 23336831)
4. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 2645-2653. (Pubitemid 38787999)
5. van der Strate BW, Postma DS, Brandsma CA, et al. Cigarette smoke-induced emphysema: a role for the B cell? Am J Respir Crit Care Med 2006; 173: 751-758.
6. Van Pottelberge GR, Bracke KR, Van den Broeck S, et al. Plasmacytoid dendritic cells in pulmonary lymphoid follicles of patients with COPD. Eur Respir J 2010; 36: 781-791.
7. Kelsen SG, Aksoy MO, Georgy M, et al. Lymphoid follicle cells in chronic obstructive pulmonary disease overexpress the chemokine receptor CXCR3. Am J Respir Crit Care Med 2009; 179: 799-805.
8. Polverino F, Baraldo S, Bazzan E, et al. A novel insight into adaptive immunity in COPD: B cell activating factor belonging to the TNF family (BAFF). Am J Respir Crit Care Med 2010; 182: 1011-1019.
9. Plumb J, Smyth LJ, Adams HR, et al. Increased T-regulatory cells within lymphocyte follicles in moderate COPD. Eur Respir J 2009; 34: 89-94.
10. Olloquequi J, Montes JF, Prats A, et al. Significant increase of CD57+ cells in pulmonary lymphoid follicles of COPD patients. Eur Respir J 2011; 37: 289-298.
11. Kalled SL. Impact of the BAFF/BR3 axis on B cell survival, germinal center maintenance and antibody production. Semin Immunol 2006; 18: 290-296. (Pubitemid 44382641)
12. Moisini I, Davidson A. BAFF: a local and systemic target in autoimmune diseases. Clin Exp Immunol 2009; 158: 155-163.
13. Sullivan AK, Simonian PL, Falta MT, et al. Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema. Am J Respir Crit Care Med 2005; 172: 590-596. (Pubitemid 41232970)
14. Lee SH, Goswami S, Grudo A, et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 2007; 13: 567-569. (Pubitemid 46828488)
15. Motz GT, Eppert BL, Wesselkamper SC, et al. Chronic cigarette smoke exposure generates pathogenic T cells capable of driving COPD-like disease in Rag2-/- mice. Am J Respir Crit Care Med 2010; 181: 1223-1233.
16. Feghali-Bostwick CA, Gadgil AS, Otterbein LE, et al. Autoantibodies in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177: 156-163.
17. Bonarius HP, Brandsma CA, Kerstjens HA, et al. Antinuclear autoantibodies are more prevalent in COPD in association with low body mass index but not with smoking history. Thorax 2011; 66: 101-107.
18. Karayama M, Inui N, Suda T, et al. Antiendothelial cell antibodies in patients with COPD. Chest 2010; 138: 1303-1308.
19. Kuo YB, Chang CA, Wu YK, et al. Identification and clinical association of anti-cytokeratin 18 autoantibody in COPD. Immunol Lett 2010; 128: 131-136.
20. Leidinger P, Keller A, Heisel S, et al. Novel autoantigens immunogenic in COPD patients. Respir Res 2009; 10: 20.
21. Brandsma CA, Kerstjens HA, Geerlings M, et al. The search for autoantibodies against elastin, collagen and decorin in COPD. Eur Respir J 2011; 37: 1289-1292.
22. Greene CM, Low TB, O'Neill SJ, et al. Anti-proline-glycine-proline or antielastin autoantibodies are not evident in chronic inflammatory lung disease. Am J Respir Crit Care Med 2010; 181: 31-35.
23. Cottin V, Fabien N, Khouatra C, et al. Anti-elastin autoantibodies are not present in combined pulmonary fibrosis and emphysema. Eur Respir J 2009; 33: 219-221.
24. Wood AM, de Pablo P, Buckley CD, et al. Smoke exposure as a determinant of auto-antibody titre in AATD and COPD. Eur Respir J 2011; 37: 32-38.
25. Eppert BL, Motz GT, Flury JL, et al. Cigarette smoke exposure leads to production of pathogenic antibodies in a murine model. Am J Respir Crit Care Med 2010; 181: A3883.
26. Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 2010; 34: J258-J265.
27. Sugiyama D, Nishimura K, Tamaki K, et al. Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 2010; 69: 70-81.
28. Costenbader KH, Kim DJ, Peerzada J, et al. Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis. Arthritis Rheum 2004; 50: 849-857. (Pubitemid 38326185)
29. Parikh-Patel A, Gold EB, Worman H, et al. Risk factors for primary biliary cirrhosis in a cohort of patients from the united states. Hepatology 2001; 33: 16-21. (Pubitemid 32016882)
30. Handel AE, Williamson AJ, Disanto G, et al. Smoking and multiple sclerosis: an updated meta-analysis. PLoS One 2011; 6: e16149.
31. Hemminki K, Liu X, Ji J, et al. Subsequent COPD and lung cancer in patients with autoimmune disease. Eur Respir J 2011; 37: 463-465.
32. Brandsma CA, Timens W, Geerlings M, et al. Induction of autoantibodies against lung matrix proteins and smoke-induced inflammation in mice. BMC Pulm Med 2010; 10: 64.
33. van Straaten JF, Coers W, Noordhoek JA, et al. Proteoglycan changes in the extracellular matrix of lung tissue from patients with pulmonary emphysema. Mod Pathol 1999; 12: 697-705. (Pubitemid 29354883)
34. Zandvoort A, Postma DS, Jonker MR, et al. Altered expression of the Smad signalling pathway: implications for COPD pathogenesis. Eur Respir J 2006; 28: 533-541. (Pubitemid 44794667)
35. Brandsma CA, Hylkema MN, Geerlings M, et al. Increased levels of (class switched) memory B cells in peripheral blood of current smokers. Respir Res 2009; 10: 108.
36. Dutch Federation of Biomedical Scientific Societies. Codes of Conduct. http://www.federa.org/gedragscodes-codes-conduct-en Date last accessed: June 12, 2012.
37. Brandsma CA, Hylkema MN, van der Strate BW, et al. Heme oxygenase-1 prevents smoke induced B-cell infiltrates: a role for regulatory T cells? Respir Res 2008; 9: 17.
38. Gosman MM, Willemse BW, Jansen DF, et al. Increased number of B-cells in bronchial biopsies in COPD. Eur Respir J 2006; 27: 60-64. (Pubitemid 43092667)
39. Pogany G, Vogel KG. The interaction of decorin core protein fragments with type I collagen. Biochem Biophys Res Commun 1992; 189: 165-172. (Pubitemid 23030022)
40. Orgel JP, Eid A, Antipova O, et al. Decorin core protein (decoron) shape complements collagen fibril surface structure and mediates its binding. PLoS One 2009; 4: e7028.
41. Schonherr E, Broszat M, Brandan E, et al. Decorin core protein fragment Leu155-Val260 interacts with TGF-beta but does not compete for decorin binding to type I collagen. Arch Biochem Biophys 1998; 355: 241-248. (Pubitemid 28364375)
42. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 1990; 346: 281-284.
43. Noordhoek JA, Postma DS, Chong LL, et al. Different modulation of decorin production by lung fibroblasts from patients with mild and severe emphysema. COPD 2005; 2: 17-25. (Pubitemid 40776218)
44. Abbas AK, Lichtman AH, Pillai S. B cell activation and antibody production. In: Cellular and Molecular Immunology. Philadelphia, Saunders Elsevier, 2007; pp. 215-241.
45. Brusselle GG, Demoor T, Bracke KR, et al. Lymphoid follicles in (very) severe COPD: beneficial or harmful? Eur Respir J 2009; 34: 219-230.
46. Kirkham PA, Caramori G, Casolari P, et al. Oxidative stress-induced antibodies to carbonyl-modified protein correlate with severity of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011; 184: 796-802.